Core Insights - The article discusses the significance of insider buying in high PE stocks, particularly in a selective market where valuations are elevated [2][3] Group 1: Insider Buying and Market Sentiment - High PE stocks are often scrutinized for their growth potential, making insider buying a noteworthy indicator of confidence in the company's future [2] - Insider transactions can signal that the market may be mispricing a company's prospects, even if the stock appears expensive [3] Group 2: Methodology for Stock Selection - The methodology involved using the Finviz screener to identify stocks with PE ratios over 30x and increased insider ownership over the last six months, focusing on companies with recent noteworthy developments [6] Group 3: Company Highlights - **Borr Drilling Limited (NYSE:BORR)**: Announced acquisition of five premium jack-up rigs for $287 million, financed through a joint venture and expected to close in Q3 [8] - **Carrier Global Corporation (NYSE:CARR)**: Made a strategic investment in Heat Geek to promote heat pump adoption in Europe, while also reporting Q4 adjusted EPS of 34 cents, below the consensus estimate [11][13]

Core Viewpoint - The recent purchase of shares by Rolf Stangl, a director at Reynolds Consumer Products, is seen as a vote of confidence in the company amidst a challenging market environment, with shares down approximately 9% over the past year [8]. Transaction Summary - Rolf Stangl purchased 4,705 common shares on March 18, 2026, valued at around $99,000, increasing his direct holdings by 13.51% to a total of 39,537 shares, which equates to an estimated market value of ~$828,000 [1][2][5]. - The transaction was executed at a weighted average purchase price of $21.06 per share [2][5]. Company Overview - Reynolds Consumer Products generated $3.72 billion in revenue for the trailing twelve months (TTM), with a net income of $301 million [4][9]. - The company has a dividend yield of 4% and has experienced a 1-year price change of -9% [4]. - The business model includes both branded and private label products across various categories, including cooking supplies, waste solutions, and disposable tableware [6][7]. Financial Performance - Revenue remained essentially flat year-over-year, while net income declined from $352 million to $301 million [9]. - Adjusted EBITDA decreased to $667 million due to pressures from softer retail volumes and higher operating costs, although pricing actions and cost controls provided some offset [9]. - Management projects 2026 revenue to range from a decline of 3% to an increase of 1%, with modest improvements in earnings expected [10].

Company Overview - Bausch + Lomb is a global leader in eye health, operating across three key segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical [7] - The company leverages a diversified product portfolio and extensive distribution network to serve healthcare professionals and consumers [7] - Bausch + Lomb generates revenue through the sale of branded and generic eye health products to healthcare providers, clinics, and direct-to-consumer channels globally [9] Financial Metrics - As of March 23, 2026, the company's stock price was $15.84, with a market capitalization of $5.61 billion [4] - The trailing twelve months (TTM) revenue was $5.10 billion, while the net income for the same period was a loss of $360 million [4] Recent Insider Activity - Alfonso Eduardo, a director at Bausch + Lomb, purchased 4,300 shares for approximately $77,000, which triggered an equal grant of 4,300 restricted share units under the company's matching share program [2][3] - This transaction increased Eduardo's total holdings from roughly 5,255 to 13,855 shares, moving him closer to a mandatory director ownership threshold of $400,000 [3] Market Context - The shares were acquired at $17.90, a small discount to the March 2 closing price of $18.41, indicating a strategic purchase aligned with the director's ownership requirements [6] - The matching program allows directors to build their equity stake efficiently while ensuring alignment with retail investors [8]

Core Insights - Insiders are actively buying stocks in 2026, indicating potential upside despite existing risks, with gains expected to develop over time [1] Group 1: E.W. Scripps (SSP) - Significant insider buying in E.W. Scripps suggests executives believe in the company's rebound potential, with purchases made by the CEO and other executives [2] - The company is focusing on efficiency through AI integration, cost reduction, and expanding its network, particularly in sports and local broadcasting [3] - Analyst coverage is mixed, with a consensus rating of "Reduce" but an 80% upside potential noted [4] - Insider buying aligns with technical indicators suggesting a market bottom, with a stock base near $4 indicating reversal potential [5] Group 2: First Financial Bankshares (FBIZ) - First Financial Bankshares has seen consistent insider buying over the past five quarters, with a historic high of over $650,000 in shares purchased in early 2026 [6] - The company offers a reliable dividend yield of about 2.5%, with book value improving by over 17.5% in fiscal 2025 and expected to continue growing [7] - Analyst coverage is limited but optimistic, forecasting about 30% upside from early March lows, with institutional ownership around 70% [8] Group 3: Crane Company (CR) - Crane Company insiders purchased shares after a solid quarterly report, raising guidance and increasing the dividend by 10%, with a low payout ratio of 15% [10] - Analysts are bullish, with a unanimous "Buy" rating and a projected 30% price increase, supported by strong institutional ownership at 75% [11] - The stock chart indicates a pullback after an uptrend, with insider buying suggesting potential for recovery [12]

Core Insights - Insiders are accumulating shares in three companies—Alkami Technology, AdaptHealth, and Tecnoglass—trading near multi-year lows, indicating confidence in their underlying cash generation and demand despite current pressures [2][4]. Alkami Technology (ALKT) - Alkami reported Q4 revenue of $120.79 million, a 34.7% increase year-over-year, with adjusted EBITDA nearly doubling to $19.14 million [7]. - The company has a net dollar retention rate of 115% and an annual recurring revenue (ARR) churn rate below 1% [7]. - General Atlantic purchased 2.8 million shares at prices between $17.35 and $18.41, despite a 28.71% decline in stock price over the past year [6][7]. - Management projects FY2026 revenue between $525.5 million and $530.5 million, with adjusted EBITDA of $93.5 million to $97.5 million [7]. AdaptHealth (AHCO) - AdaptHealth's operating cash flow for the full year reached $601.77 million, an 11.06% increase year-over-year [9]. - Richard Cashin acquired 2 million shares at approximately $9.73, although the stock has seen a 71.5% decline over the past five years [8][9]. - The company faced a significant earnings miss due to a $128 million non-cash goodwill impairment in its Diabetes Health unit [9]. - Management guided FY2026 adjusted EBITDA to be between $680 million and $730 million, with free cash flow projected at $175 million to $225 million [9]. Tecnoglass (TGLS) - Tecnoglass reported record Q4 revenue of $245.30 million, a 16.1% increase year-over-year, and holds a record backlog of $1.30 billion [10]. - The stock has declined 31.17% over the past year, influenced by margin compression from high aluminum costs and currency fluctuations [10]. - Energy Holding has been accumulating shares near 52-week lows, reflecting confidence in the company's future revenue visibility [10]. - The forward P/E ratio is approximately 10x, with an analyst consensus target of $66.25, indicating significant upside potential from the current price of $45.71 [10].

Core Insights - Simply Good Foods (SMPL) shares have decreased by 54% over the past year, currently priced at $17.05, compared to a 52-week high of $38.16, indicating significant market volatility [1] - The return of founder Joe Scalzo as CEO on January 19, 2026, has shifted market sentiment positively, with Reddit sentiment increasing from 60 to 72 out of 100, primarily due to insider buying activity [1] - Scalzo's return raises questions about whether he can effectively turn around the company or if he is merely a temporary leader in a struggling organization [1] Company Performance - Simply Good Foods has experienced a substantial decline in stock value, with shares falling to $17.05 from a high of $38.16 over the past year [1] - The company's CFO purchased $199,000 worth of shares, signaling confidence in the company's future [1] - Scalzo received 2 million stock options upon his return, which may align his interests with those of shareholders [1] Market Sentiment - The sentiment score for Simply Good Foods on Reddit has stabilized at a bullish 72 out of 100, reflecting a positive outlook among retail investors [1] - A notable Reddit post highlighted the bullish sentiment surrounding Scalzo's return and insider buying, accumulating 122 upvotes and 25 comments, indicating strong community engagement [1] - The market is currently evaluating Scalzo's potential impact on the company's future performance and overall strategy [1]

Core Viewpoint - The individual investor adopts a contrarian investment style, focusing on stocks that have recently experienced sell-offs due to non-recurrent events, particularly when insiders are buying shares at lower prices [1] Investment Strategy - The investment portfolio is split approximately 50%-50% between shares and call options, indicating a balanced approach to risk and potential returns [1] - The investor's timeframe for holding positions typically ranges from 3 to 24 months, suggesting a medium-term investment horizon [1] - Fundamental analysis is employed to assess the health of companies, including their leverage and financial ratios compared to sector and industry averages [1] - Technical analysis is utilized to optimize entry and exit points, with a focus on support and resistance levels on weekly charts [1] Stock Selection Criteria - The investor screens for stocks that have undergone recent sell-offs, particularly those influenced by non-recurrent events, to identify potential buying opportunities [1] - Insider buying at lower prices serves as a key indicator for selecting stocks, reflecting confidence from company executives [1] - Professional background checks are conducted on insiders who purchase shares post-sell-off to ensure credibility and assess motivations [1]

Group 1 - Insider buying was prominent in Q4 2025, indicating potential value in underappreciated stocks, with a focus on three specific stocks, one of which has a simple and effective technology that is in demand [3] - Alight (NYSE: ALIT) is a cloud-based employee engagement platform with significant insider buying activity, particularly in Q4 2025, where insiders own about 2% of the stock, while institutions hold the majority [4] - BlackRock has made a substantial investment in Nebius Group, despite high short interest near 7%, which is impacting stock price, although profitability and dividends are strong, with an annualized return of 12% expected in early 2026 [5] Group 2 - The stock price of Nebius Group is currently around $1.30, below analysts' lowest target, suggesting a potential 200% upside relative to consensus, with increasing trading volume indicating a possible rebound [6] - Insider purchases have accelerated in late 2025 across three companies, highlighting a combination of heavy insider ownership and tightly held floats, which could lead to significant price movements if commercialization increases [6]

Core Insights - The article discusses the significance of insider buying in dividend stocks amidst concerns over a recent executive order affecting CEO pay, dividends, and stock buybacks in the U.S. defense sector [2][3][4] Group 1: Insider Buying and Market Sentiment - Insider buying is highlighted as a reliable indicator for investors, as insiders possess first-hand information about their companies [4] - The article references Peter Lynch's philosophy that insiders buy shares when they believe the price will rise, emphasizing the importance of insider transactions [5] Group 2: Methodology for Stock Selection - The list of 12 dividend stocks with high insider buying was compiled using the Finviz stock screener, focusing on stocks with insider ownership of 10% or more [8] - The stocks were ranked based on insider ownership and included data on hedge fund holdings from Q3 2025 to provide additional insights into investor interest [8][10] Group 3: Company-Specific Insights - Paychex, Inc. (NASDAQ:PAYX) has a dividend yield of 4.45% and insider ownership of 10.32%, with significant insider purchases made on February 5, 2026 [11] - Kinder Morgan, Inc. (NYSE:KMI) has a dividend yield of 3.72% and insider ownership of 12.79%, with notable insider activity including a purchase by a director on February 3, 2026, and a dividend increase of 2% announced for Q4 2026 [15][18]

Core Insights - Insider buying has been observed in four notable companies: KKR, Reddit, SpyGlass Pharma, and Veradermics, indicating management's confidence in their future prospects [1] Group 1: Insider Buying Activity - SpyGlass Pharma saw significant insider purchases, with RA Capital Management acquiring approximately 3.7 million shares and NEA adding 937,500 shares at the IPO price of $16.00 per share [1] - Veradermics had Suvretta Capital Management purchase 282,700 shares at a weighted average price of about $36.50, totaling $10.5 million, reflecting a nearly 20% increase in their stake over six months [1] - Reddit's director bought 50,500 shares between $139.11 and $150.00, totaling nearly $7.5 million, marking one of the first major purchases post-IPO lock-up [1] - KKR's director purchased 50,000 shares at prices ranging from $104.36 to $107.10, totaling over $5.2 million, amidst a 22.5% stock retreat in the past month [1] Group 2: Company Performance and Analyst Sentiment - SpyGlass Pharma's stock is trading near $28.20, above the IPO price, with analysts giving a Strong Buy consensus due to its potential in the $5 billion glaucoma market [1] - Veradermics received an Overweight rating from Wells Fargo following successful Phase 3 trial enrollment, with shares currently at $43.46, reflecting a 19% gain for insiders [1] - Reddit's stock is currently at $139.65, with analysts remaining bullish on its high-margin data licensing deals despite recent volatility [1] - KKR reported record assets under management exceeding $740 billion, with analysts optimistic about private equity firms benefiting from the IPO market reopening [1]